<DOC>
	<DOCNO>NCT01522937</DOCNO>
	<brief_summary>This Phase II trial characterize safety efficacy individualize stereotactic body radiation therapy ( SRBT ) patient previous liver treatment primary hepatocellular carcinoma ( HCC ) .</brief_summary>
	<brief_title>A Study Individualized Stereotactic Body Radiation Therapy ( SBRT ) Intrahepatic Cancer</brief_title>
	<detailed_description>The trial endpoint toxicity , survival progression-free survival . DCE-MRI plasma biomarkers also collect explore use tool treatment individualization future trial . During current trial , indicator liver function , indocyanine green ( ICG ) , use identify treatment patient excess risk radiation-induced liver disease ( RILD ) radiation dose may reduce . The model use individualization updated trial data accrue , adaptive trial individualized therapy . The planned accrual seventy ( 70 ) evaluable patient three year .</detailed_description>
	<mesh_term>Liver Neoplasms</mesh_term>
	<criteria>age 18 life expectancy least 12 week Zubrod performance status ≤2 . biopsy proven hepatocellular carcinoma ( HCC ) liver metastases discrete hepatic tumor ( ) define Barcelona46 criterion cirrhotic patient , ( 1 ) 2 image study show hypervascular tumor &gt; 2cm , ( 2 ) single image study show hypervascular tumor &gt; 2cm AFP ≥ 400 ng/mL discrete hypervascular tumor present two consecutive image study ( CT MRI ) document growth &gt; 1cm diameter adequate organ function woman men interested pregnancy must recover effect prior surgery , radiation therapy , chemotherapy effect Radiofrequency Ablation ( RFA ) Transcatheter Arterial Chemo Embolization ( TACE ) minimum 6 week follow last surgical procedure , radiation chemotherapy . eligible curative liver resection uncontrolled ascites clinically evident physical exam know allergy ICGreen know allergy intravenous iodinate contrast agent patient poor venous access patient metastatic cancer normal liver function undergone previous liver direct therapy single tumor &lt; 6 cm size .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>